Human Embryonic Stem Cells (hESC) - A Global Market Overview

Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down. Stem cells are unspecialized cells that are capable of differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research for finding cures for a host of diseases. Adult, umbilical cord blood and embryos constitute the three sources of stem cells, of which embryonic stem cells have been the subject of major research activities.

Embryonic Stem Cell Technologies analyzed in this study include Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other. The report also analyzes the market for hESC therapeutic areas including Central Nervous System (CNS), Tissue Engineering, Oncology, Cardiology and Other Disease Areas.The worldwide market for hESCs is estimated at US$3.8 billion in 2010. Growing at a robust CAGR of 24.8% during the period 2007-2015, the market is projected to reach US$10.7 billion by 2015, .

The report reviews, analyses and projects the hESCs market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 12 independent countries across North America – United States, Canada and Mexico; Europe – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe; Asia-Pacific –India, China, Japan, Australia and Rest of Asia-Pacific.

This 216 page global market report includes 106 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments. The study also profiles 41 key global players and 55 major players across North America – 28; Europe – 15; Asia-Pacific – 10 and Rest of World - 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of hESCs. The global list of companies covers addresses, contact numbers and the website addresses of 184 companies. SHOW LESS READ MORE >

1. GLOBAL MARKET PERSPECTIVE

1.1 Introduction
1.2 Product Segmentation
1.2.1 Technologies of hESCs
1.2.1.1 Stem Cell Transplants
Infarcted Myocardium to be repaired by Human Embryonic Stem Cell Transplantation
Oligodendrocyte Progenitor Cell Transplants Derived from Human Embryonic Stem Cells Enhance Recovery after Cervical Spinal Cord Injury
Human Embryonic Stem Cell-Derived Cardiomyocytes Transplantation Improves Myocardial Performance in Infarcted Rat Hearts
1.2.1.2 Cell Based Genomics
Genomic Alterations in Cultured Human Embryonic Stem Cells
Gene Expression in Human Embryonic Stem Cell Lines: Unique Molecular Signature
GeneChip Analysis of Human Embryonic Stem Cell Differentiation into Hemangioblasts: An In Silico Dissection of Mixed Phenotypes
1.2.1.3 Xenotransplantation
1.2.1.4 Other Stem Cell Technologies
1.2.2 Therapeutic Areas of hESCs
1.2.2.1 Central Nervous System
1.2.2.2 Tissue Engineering
Endochondral Bone Tissue Engineering Using Embryonic Stem Cells
Bone Tissue Engineering in an Orthotopic Defect
Discussion
1.2.2.3 Oncology

Embryonic Stem Cells Reveal Secret Growth Formula of Oncogene

1.2.2.4 Cardiology

1.2.2.5 Other Therapeutic Areas

Blood Disorders

Diabetes

Muscular Dystrophy

Stem Cell Therapy for Spinal Cord Injury

1.2.3 Pros and Cons of Embryonic Stem Cell Research

1.3 Snapshot on Global hESC Laws and Patents

1.3.1 The United States

Patent on Human Embryonic Stem Cells Rejected After Consumer Groups' Appeal

1.3.2 Europe

Stem Cell Patent Rejected by Europe

1.3.3 Asia-Pacific

China

Laws and Regulations

Cultural Views

Australia

India

Indonesia

Japan

Taiwan

Patent Policy

Thailand

Singapore

South Korea

1.4 A Glance at Existing Stem Cell Research Policies Worldwide

1.4.1 hESC Research Policy by Region

North America

Europe

Asia-Pacific

Rest of World

1.4.2 Status of Stem Cell Research

1.5 Market Trends

Human Embryonic Stem Cells Hold Promises for Medical Advances

hESC In Toxicology Applications

Stem Cells Hold Promise to Predict Disease and Drug Toxicity

Scientists Create More Pluripotent Human Embryonic Stem Cells

Latest Trends in Treating HIV and AIDS with Stem Cell Therapies

Embryonic Stem Cells Promise New Cures

Does Bill Expanding Obama's Embryonic Stem Cell Research Order Promote Cloning?

Israeli Stem Cell Researchers Achieve Breakthrough in Cell Growth Method

Reactive Oxygen Species Enhance Differentiation of hESCs into Mesendodermal Lineage

Federal Policy Allows Funding for New hESC Lines but not all Investigators are Happy with the Changes

Human Skin Grown from Stem Cells to Help Burns Victims

UCI Embryonic Stem Cell Therapy Restores Walking Ability in Rats with Neck Injuries

Human Embryonic Stem Cell Differentiation on Periodontal Ligament Fibroblasts

Technique Enables Efficient Gene Splicing in Human Embryonic Stem Cells

Human Sperm Created from Embryonic Stem Cells

hESC Technologies and Drug Discovery

Stem Cell Therapy for Blindness

Expansion and Differentiation of hESC to Endoderm Progeny in a Microcarrier Stirred-Suspension Culture

Geron Commences Human Embryonic Stem Cell Therapy for Spinal Cord Injuries

Nanotechnology for Regenerative Medicine: Nanomaterials for Stem Cell Imaging

Therapeutic Potential of hESC in Parkinson’s disease

1.6 Key Global Players

1.7 Key Business Trends

BioTime, Inc Acquires ES Cell International Pte Ltd

PerkinElmer to Acquire Signature Genomic Laboratories, LLC

Proxeon Acquired by Thermo Fisher Scientific

Stemgent, Pfizer in a Collaboration Research and Licensing Agreement

Thermo Fisher Scientific Takes Over Ahura Scientific

Human Embryonic Stem Cells with Enhanced Pluripotency Created by Scientists

Stemcell Technologies Inc Releases Two NEW Human Treg Cell Isolation Kits

Pfizer Acquires Wyeth

Thermo Fisher Scientific Acquires B.R.A.H.M.S.

PerkinElmer Takes Over Prenatal and Newborn Screening Laboratory in India

StemCells, Inc Plans to Enhance Cell-Based Technologies for Pharmaceutical Industry and Research Applications

Thermo Fisher Scientific to Acquire Biolab

Embryome Sciences, Inc Enters into an Agreement with Reproductive Genetics Institute

StemCells, Inc. to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc

Geron Gets the Green Signal from FDA to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy

Advanced Cell Technology, Inc and CHA Biotech Co, Ltd in a Joint Venture

BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit Launched by BD Biosciences

BioTime to Work with Longevity Center on Regenerative Medicine Research

Embryome Sciences, Inc. Acquires Exclusive License for ACTCellerate Technology

Thermo Fisher Scientific Acquires Affinity BioReagents

Thermo Fisher Scientific Acquires Open Biosystems

MedCell Joins Forces with NovaThera

Pfizer Acquires Encysive Pharmaceuticals Inc

BD Acquires Cytopeia

Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement

BI Biotech India Pvt. Ltd, GlobalStem Inc Enter into Partnership

1.8 Global Market Overview

1.8.1 Market Overview by hESC Technology

1.8.2 Market Overview by hESC Therapeutic Area

1.8.3 hESC Technology Market Overview by Global Region

1.8.3.1 Stem Cell Transplants

1.8.3.2 Cell Based Genomics

1.8.3.3 Xenotransplants

1.8.3.4 Other Stem Cell Technologies

1.8.4 hESC Therapeutic Area Market Overview by Global Region

1.8.4.1 Central Nervous System (CNS)

1.8.4.2 Tissue Engineering

1.8.4.3 Oncology

1.8.4.4 Cardiology

1.8.4.5 Other Disease Areas

2. REGIONAL MARKET PERSPECTIVE

2.1 Regional Market Overview

2.1.1 North America

2.1.1.1 Market Overview by North American Region

2.1.1.2 Market Overview by hESC Technology

2.1.1.3 Market Overview by hESC Therapeutic Area

2.1.1.4 hESC Technology Market Overview by North American Region

Stem Cell Transplants

Cell Based Genomics

Xenotransplants

Other Stem Cell Technologies

2.1.1.5 Major Market Players

Amgen
Advanced Cell Technology, Inc

Americans for Cures Foundation

Angioblast Systems, Inc

BD Biosciences

BioTime

California Stem Cell

Cellular Dynamics International

Geron Corporation

GlobalStem Inc

International Society for Stem Cell Research

International Stem Cell Corporation

Millipore Corporation

National Human Neural Stem Cell Resource

PerkinElmer Inc.

Pfizer

R&D Systems, Inc.

SA Biosciences Corporation

Stem Cell Network (Canada)

Stem Cell Technologies (Canada)

Stem Cell Therapy International Corporation

StemCells Inc.

Stemina Biomarker Discovery, Inc.

The New York Stem Cell Foundation

Thermo Fisher Scientific Inc

ViaCell, Inc.

ViaCyte

WiCell International Stem Cell (WISC) Bank

2.1.1.6 North American Market Overview by Country

The United States

Canada

Mexico

2.1.2 Europe

2.1.2.1 Market Overview by European Region

2.1.2.2 Market Overview by hESC Technology

2.1.2.3 Market Overview by hESC Therapeutic Area

2.1.2.4 hESC Technology Market Overview by European Region

Stem Cell Transplants

Cell Based Genomics

Xenotransplants

Other Stem Cell Technologies

2.1.2.5 Major Market Players

Angel Biotechnology (United Kingdom)

Axiogenesis AG (Germany)

Boehringer-Ingelheim GmbH (Germany)
Cellartis AB (Sweden)

ESTOOLS (United Kingdom)

GE Healthcare (United Kingdom)
Novartis AG (Switzerland)
Novo Nordisk A/B (Denmark)

Regenics A/S (Norway)

Sanofi-Aventis (France)
Scottish Stem Cell Network (United Kingdom)

Stemride International Ltd (United Kingdom)

TATAA Biocenter (Sweden)

UK National Stem Cell Network (United Kingdom)

UK Stem Cell Bank (UKNSCB) (United Kingdom)

2.1.2.6 European Market Overview by Country

The United Kingdom

Germany

France

Spain

Sweden

Rest of Europe

2.1.3 Asia-Pacific

2.1.3.1 Market Overview by Asia-Pacific Region

2.1.3.2 Market Overview by hESC Technology

2.1.3.3 Market Overview by hESC Therapeutic Area

2.1.3.4 hESC Technology Market Overview by Asia-Pacific Region

Stem Cell Transplants

Cell Based Genomics

Xenotransplants

Other Stem Cell Technologies

2.1.3.5 Major Market Players

Australian Stem Cell Centre (Australia)

CellResearch Corporation Pte Ltd (Singapore)

National Center for Biological Sciences (India)

New South Wales Stem Cell Network (Australia)

Reliance Life Sciences (India)

RNL BIO (South Korea)

SinoCells BioTechnologies Co., Ltd. (China)

Stem Cell Sciences KK (Japan)

StemTech International Sdn Bhd (Malaysia)

Taiwan Society for Stem Cell Research (Taiwan)

2.1.3.6 Asia-Pacific Market Overview by Country

India

Role of Governing Bodies

Latest Trends in Stem Cells Therapy

Future of Stem Cells in India Primed for Growth

Indian Stem Cells’ Company Scenario

Outlook

China

Japan

Australia

Rest of Asia-Pacific

2.1.4 Rest of World

2.1.4.1 Market Overview by Rest of World Region

2.1.4.2 Market Overview by hESC Technology

2.1.4.3 Market Overview by hESC Therapeutic Area

2.1.4.4 Major Market Players

Cell Cure Neurosciences Ltd. (Israel)

Gamida Cell Ltd. (Israel)

3. GUIDE TO THE INDUSTRY

3.1 North America

3.1.1 Canada

3.1.2 United States

3.2 Europe

3.2.1 Denmark

3.2.2 France

3.2.3 Germany

3.2.4 Norway

3.2.5 Spain

3.2.6 Sweden

3.2.7 Switzerland

3.2.8 The Netherlands

3.2.9 United Kingdom

3.3 Asia-Pacific

3.3.1 Australia

3.3.2 China

3.3.3 India

3.3.4 Japan

3.3.5 Korea

3.3.6 Malaysia

3.3.7 Singapore

3.3.8 South Korea

3.3.9 Taiwan

3.3.10 Thailand

3.4 Rest of World

3.4.1 Israel

3.4.2 South Africa

4. ANNEXURE

4.1 Research methodology

4.2 The Questionnaire

4.3 Feedback

Charts & Graphs

GLOBAL MARKET PERSPECTIVE
Chart 1: Stem Cell Types – Properties

Chart 2: Stem Cell Research (2009): The Nations with Embryos Created for Research by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 3: Stem Cell Research (2009): The Nations with Existing Stem Cell Lines by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 4: Stem Cell Research (2009): The nations with No Explicit Stem Cell Research Policy by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 5: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in USD Million

Chart 6: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 7: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Chart 8: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million

Chart 9: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other

Chart 10: Global Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 11: Glance at 2007, 2010 and 2015 Global Stem Cell Transplants Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 12: Global Cell Based Genomics Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 13: Glance at 2007, 2010 and 2015 Global Cell Based Genomics Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 14: Global Xenotransplants Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 15: Glance at 2007, 2010 and 2015 Global Xenotransplants Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 16: Global Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 17: Glance at 2007, 2010 and 2015 Global Other Stem Cell Technologies Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 18: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in CNS by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 19: Glance at 2007, 2010 and 2015 Global CNS Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 20: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Tissue Engineering by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 21: Glance at 2007, 2010 and 2015 Global Tissue Engineering Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 22: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Oncology by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 23: Glance at 2007, 2010 and 2015 Global Oncology Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 24: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Cardiology by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 25: Glance at 2007, 2010 and 2015 Global Cardiology Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

Chart 26: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Other Disease Areas by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 27: Glance at 2007, 2010 and 2015 Global Other Disease Areas Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET PERSPECTIVE
Chart 28: The Projection of Largest Regions in terms of Market Growth for Human Embryonic Stem Cells by Geography – Asia-Pacific, Europe and North America

Chart 29: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million

Chart 30: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

NORTH AMERICA
Chart 31: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million

Chart 32: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%) by Geographic Region – United States, Canada and Mexico

Chart 33: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 34: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Chart 35: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million

Chart 36: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%)by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other

Chart 37: North American Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million

Chart 38: Glance at 2007, 2010 and 2015 North American Stem Cell Transplants Market Share (%) by Geographic Region – United States, Canada and Mexico

Chart 39: North American Cell Based Genomics Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million

Chart 40: Glance at 2007, 2010 and 2015 North American Cell Based Genomics Market Share (%) by Geographic Region – United States, Canada and Mexico

Chart 41: North American Xenotransplants Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million

Chart 42: Glance at 2007, 2010 and 2015 North American Xenotransplants Market Share (%) by Geographic Region – United States, Canada and Mexico

Chart 43: North American Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million

Chart 44: Glance at 2007, 2010 and 2015 North American Other Stem Cell Technologies Market Share (%) by Geographic Region – United States, Canada and Mexico

The United States
Chart 45: United States Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 46: Glance at 2007, 2010 and 2015 United States Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Canada
Chart 47: Canadian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 48: Glance at 2007, 2010 and 2015 Canadian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Mexico
Chart 49: Mexican Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 50: Glance at 2007, 2010 and 2015 Mexican Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

EUROPE
Chart 51: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million

Chart 52: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe

Chart 53: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 54: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Chart 55: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million

Chart 56: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other

Chart 57: European Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million

Chart 58: Glance at 2007, 2010 and 2015 European Stem Cell Transplants Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe

Chart 59: European Cell Based Genomics Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million

Chart 60: Glance at 2007, 2010 and 2015 European Cell Based Genomics Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe

Chart 61: European Xenotransplants Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million

Chart 62: Glance at 2007, 2010 and 2015 European Xenotransplants Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe

Chart 63: European Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million

Chart 64: Glance at 2007, 2010 and 2015 European Other Stem Cell Technologies Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe

United Kingdom
Chart 65: United Kingdom Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 66: Glance at 2007, 2010 and 2015 United Kingdom Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Germany
Chart 67: German Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 68: Glance at 2007, 2010 and 2015 German Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

France
Chart 69: French Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 70: Glance at 2007, 2010 and 2015 French Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Spain
Chart 71: Spanish Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 72: Glance at 2007, 2010 and 2015 Spanish Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Sweden
Chart 73: Swedish Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 74: Glance at 2007, 2010 and 2015 Swedish Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Rest of Europe
Chart 75: Rest of Europe Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 76: Glance at 2007, 2010 and 2015 Rest of Europe Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

ASIA-PACIFIC
Chart 77: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million

Chart 78: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific

Chart 79: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 80: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Chart 81: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million

Chart 82: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other

Chart 83: Asia-Pacific Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million

Chart 84: Glance at 2007, 2010 and 2015 Asia-Pacific Stem Cell Transplants Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific

Chart 85: Asia-Pacific Cell Based Genomics Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million

Chart 86: Glance at 2007, 2010 and 2015 Asia-Pacific Cell Based Genomics Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific

Chart 87: Asia-Pacific Xenotransplants Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million 170
Chart 88: Glance at 2007, 2010 and 2015 Asia-Pacific Xenotransplants Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific

Chart 89: Asia-Pacific Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million

Chart 90: Glance at 2007, 2010 and 2015 Asia-Pacific Other Stem Cell Technologies Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific

India
Chart 91: Indian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 92: Glance at 2007, 2010 and 2015 Indian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

China
Chart 93: Chinese Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 94: Glance at 2007, 2010 and 2015 Chinese Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Japan
Chart 95: Japanese Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 96: Glance at 2007, 2010 and 2015 Japanese Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Australia
Chart 97: Australian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 98: Glance at 2007, 2010 and 2015 Australian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Rest of Asia-Pacific
Chart 99: Rest of Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 100: Glance at 2007, 2010 and 2015 Rest of Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

REST OF WORLD
Chart 101: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – Brazil, Israel, Columbia, Africa and Other in USD Million

Chart 102: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Geographic Region – Brazil, Israel, Columbia, Africa and Other

Chart 103: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million

Chart 104: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Chart 105: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million

Chart 106: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other

- Advanced Cell Technology, Inc
- Amgen
- Angel Biotechnology
- Australian Stem Cell Centre
- Axiogenesis AG
- BD Biosciences
- BioTime
- Boehringer-Ingelheim GmbH
- Cellartis AB
- CellResearch Corporation Pte Ltd
- Cellular Dynamics International
- ESTOOLS
- Gamida Cell Ltd.
- GE Healthcare
- Geron Corporation
- GlobalStem Inc
- International Stem Cell Corporation
- Millipore Corporation
- National Human Neural Stem Cell Resource
- Novartis AG
- Novo Nordisk A/B
- PerkinElmer Inc.
- Pfizer
- R&D Systems, Inc.
- Regenics A/S
- Reliance Life Sciences
- RNL BIO
- SA Biosciences Corporation
- Sanofi-Aventis
- Scottish Stem Cell Network
- SinoCells BioTechnologies Co., Ltd.
- Stem Cell Network
- Stem Cell Sciences KK
- StemCells Inc.
- Stemina Biomarker Discovery, Inc.
- StemTech International Sdn Bhd
- Taiwan Society for Stem Cell Research
- Thermo Fisher Scientific Inc
- UK National Stem Cell Network
- UK Stem Cell Bank (UKNSCB)
- ViaCell, Inc.